Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5775 Wayzata Blvd
Ste 255
Edina, MN 55416Phone+1 952-525-4450Fax+1 952-525-1560
Education & Training
Massachusetts General Hospital/Harvard Medical SchoolFellowship, Clinical Neurophysiology, 2008 - 2009
Tufts Medical CenterFellowship, Child Neurology, 2005 - 2008- Tufts Medical CenterResidency, Pediatrics, 2003 - 2005
Vanderbilt University School of MedicineClass of 2003
Certifications & Licensure
MN State Medical License 2017 - 2025
CA State Medical License 2011 - 2019
MA State Medical License 2008 - 2013
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Epilepsy
Clinical Trials
- Effects of Music Based Intervention (MBI) on Pain Response and Neurodevelopment in Preterm Infants Start of enrollment: 2020 Nov 20
Publications & Presentations
PubMed
- Rising pressure to understand the risks of hypertension in children with narcolepsy type 1.Elizabeth Montesano, Maria E Garcia, Shannon Lyon, Jennifer Worhach, Grace Wang
Journal of Clinical Sleep Medicine. 2025-03-19 - Impaired sleep-dependent memory consolidation in pediatric narcolepsy type 1.Kiran Maski, Gillian Heckler, Jennifer Worhach, Dimitrios Mylonas, Grace Wang
Sleep. 2025-02-10 - 1 citationsTen Reasons Why Neurologists Should Refer Patients With Alzheimer Dementia to Music Therapy.Shauna H Yuan, Michael J Silverman, Andrea M Cevasco-Trotter, Sonya G Wang
Neurology. Clinical Practice. 2024-12-01
Grant Support
- Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for TicsUNIVERSITY OF MINNESOTA2023–2028
- NEOLEV3: A Phase IIb Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures of Mild to Moderate Severity IND-109622 (September 6, 2020)UNIVERSITY OF MINNESOTA2022–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
